Cargando…
Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease originating from a mutation in genes encoding polycystin 1 and 2. Recent evidence suggests that these polycystins mediate mechanosensation not only in the primary cilium of kidney cells but also in bone cells. Th...
Autores principales: | Jankowska, Magdalena, Haarhaus, Mathias, Qureshi, Abdul Rashid, Lindholm, Bengt, Evenepoel, Pieter, Stenvinkel, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678633/ https://www.ncbi.nlm.nih.gov/pubmed/29142975 http://dx.doi.org/10.1016/j.ekir.2017.01.001 |
Ejemplares similares
-
Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023) -
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease
por: Janssens, Peter, et al.
Publicado: (2021) -
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019) -
Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease
por: Jankowska, Magdalena, et al.
Publicado: (2015) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)